UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (date of earliest event reported):
November 4, 2011


CHEMED CORPORATION
(Exact name of registrant as specified in its charter)

Delaware

1-8351

31-0791746

(State or other

jurisdiction of

incorporation)

(Commission File Number)

(I.R.S. Employer

Identification

Number)

2600 Chemed Center, 255 East 5th Street, Cincinnati, OH 45202

(Address of principal executive offices)           (Zip Code)


Registrant’s telephone number, including area code:
(513) 762-6900


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1 of 2

Item 8.01     Other Events

Chemed Corporation issued a press release on November 7, 2011 announcing its Board of Directors, at its November 4, 2011 meeting, formally authorized an additional $100 million for stock repurchase under Chemed’s existing share repurchase program.  These share repurchases will be funded through cash generated from operations as well as utilization of the company’s revolving credit facility.

The Board of Directors also declared a quarterly cash dividend of 16 cents per share on the Company’s capital stock, payable on December 7, 2011 to share holders of record as of November 17, 2011.

              A copy of the release is filed herewith as Exhibit 99

Item 9.01     Financial Statements and Exhibits

d)      Exhibit

(99) Registrant’s press release dated November 7, 2011                              




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CHEMED CORPORATION

 

 

Dated:

November 7, 2011

By:

  /s/  Arthur V. Tucker, Jr.

Arthur V. Tucker, Jr.

Vice President and Controller

2 of 2